Blog, Hepatitis C

How Long will a Person Live with Hep C?

Sofosbuvir 400 mg

Sofosbuvir 400 mg for Hep C

Hep C is a liver infection that seriously damages the liver and causes liver inflammation. When the Hep C virus becomes aggressive, it can even lead to scarring of the liver or liver cirrhosis. Research says that a person with hep C can stay alive for many years without noticing any signs or symptoms. Symptoms or signs tend to show up when a person already undergoes severe liver damage that can negatively impact the treatment as well as the prognosis.

Hepatitis C has two stages- Acute and Chronic stage. Nearly 75% to 85% of acute hepatitis C cases become severe and advance to the chronic stage. Signs of liver inflammation or damage may appear when a person suffers from chronic hep C that becomes detected after blood screening. Chronic hepatitis C requires strong medications like Daclatasvir 60mg + Sofosbuvir 400 mg and other effective forms of treatment for preventing liver damage, cirrhosis, and other health complications. Liver scarring and liver cancer can impact overall life expectancy and prognosis.

Acute HCV

Sofosbuvir 400 mg tablets for Hep CMost of the people living with help C get cleared of this virus from their immune system on their own without receiving any treatment or medication. Acute HCV is a short-lived viral infection that does not cause severe complications. Sofosbuvir and daclatasvir are effective medications that help treat HCV. You can learn about the side effects, sofosbuvir 400 mg and daclatasvir 60 mg price and strength from your healthcare team.

Outlook of acute HCV

If your healthcare team can diagnose and detect acute hepatitis C infection in the early stages, then they can monitor the virus and prevent the progression of the infection to the chronic stage. The risk of serious complications and death due to acute HCV is very low. However, if your immune system does not get cleared of this virus spontaneously within six months of hep C infection, then the stage can aggravate and advance to the chronic stage. Drugs like sofosbuvir 400 mg can help a person living with hep C to lead longer and healthier lives.

Chronic HCV

People who are diagnosed and treated with acute HCV before developing any liver scarring or damage lead a better life. The outlook of those individuals is better than those who do not receive timely treatment and have already developed liver damage or scarring. Diagnosing and detecting hep C infection in the early stages enables a person to live longer and get cured of the virus. Potential symptoms for chronic hep C cirrhosis are liver damage, liver failure, and liver cancer. Sofosbuvir is a targeted treatment that helps to improve the outcome for people suffering from this infection. You can know about sofosbuvir 400 mg price from your local pharmacy.

Outlook of chronic HCV

Sofosbuvir 400 mg from aprazer
The liver becomes severely damaged with hep C as a result of inflammation. It can also lead to cirrhosis which is a scarring of the liver. Around 10% to 20% of people living with this virus can develop liver cirrhosis within a period of 20 or 30 years, while 3 to 6% suffer from liver failure, and only 1- 5% suffer from liver cancer. Nearly 25% of people get this virus cleared from their system on their own, while the majority suffer from chronic infection.

Treatment

The right treatment for hep C will be determined by factors such as health conditions and the genotype of the hep C virus. More advancements are taking place in medical science to enable a person to lead a normal, healthier, and active life after getting diagnosed with HCV. Effective medications like Sofokast Plus(sofosbuvir 400 mg and daclatasvir 60 mg) help to treat the hep C virus in a better way. Other treatments include oral medication, direct-acting antivirals, etc. The prognosis for hep C depends on the right diagnosis and treatment plan. Early detection and screening can help people get clear of this virus quickly.

Leave a Reply

Your email address will not be published. Required fields are marked *